CORDIS
EU research results

CORDIS

English EN

Early clinical development of a live, attenuated combination vaccine against Shigella and ETEC diarrhoea

Project information

Grant agreement ID: 815568

Status

Ongoing project

  • Start date

    1 September 2019

  • End date

    31 August 2024

Funded under:

H2020-EU.3.1.3.

Coordinated by:

EUROPEAN VACCINE INITIATIVE EWIV

Germany

Project description

Coordinator

EUROPEAN VACCINE INITIATIVE EWIV

Address

Vossstrasse 2 Geb 4040
69115 Heidelberg

Germany

Activity type

Research Organisations

EU Contribution

€ 359 755

Participants (4)

EVELIQURE BIOTECHNOLOGIES GMBH

Austria

EU Contribution

€ 5 024 401,62

GOETEBORGS UNIVERSITET

Sweden

EU Contribution

€ 749 842,50

INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH BANGLADESH

Bangladesh

EU Contribution

€ 1 924 713,27

PATH

United States

EU Contribution

€ 545 277,54

Project information

Grant agreement ID: 815568

Status

Ongoing project

  • Start date

    1 September 2019

  • End date

    31 August 2024

Funded under:

H2020-EU.3.1.3.

Coordinated by:

EUROPEAN VACCINE INITIATIVE EWIV

Germany